ClinicalThought

Share

Program Content

Activities

  • Targeting AML
    The Importance of Molecular and Cytogenetic Targets in AML
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 12, 2018

    Expires: September 11, 2019

  • Targeted AML Therapies
    A New Paradigm: Targeted Therapies for Acute Myeloid Leukemia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 15, 2018

    Expires: October 14, 2019

  • ASH 2018: New AML Data
    Promising Developments in AML From ASH 2018
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 27, 2018

    Expires: December 26, 2019

Faculty

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Gary J. Schiller, MD

Professor
Division of Hematology/Oncology
Department of Medicine
Director, Hematological Malignancy/Stem Cell Transplantation
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Novartis Pharmaceuticals Corporation